CAPRICOR THERAPEUTICS, INC. Increase (Decrease) in Prepaid Expense and Other Assets
CAPRICOR THERAPEUTICS, INC. (CAPR) reported Increase (Decrease) in Prepaid Expense and Other Assets of -$1.06 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-08-14
- CAPRICOR THERAPEUTICS, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was -$81.83K.
- CAPRICOR THERAPEUTICS, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was -$979.78K.
- CAPRICOR THERAPEUTICS, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-12-31 was $3.33M, a 226.58% increase year-over-year.
- CAPRICOR THERAPEUTICS, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was $966.33K.
- CAPRICOR THERAPEUTICS, INC. increase (decrease) in prepaid expense and other assets for fiscal 2025 was $4.09M, a 792.53% increase from fiscal 2024.
- CAPRICOR THERAPEUTICS, INC. increase (decrease) in prepaid expense and other assets for fiscal 2024 was $458.65K, a 504.41% increase from fiscal 2023.
- CAPRICOR THERAPEUTICS, INC. increase (decrease) in prepaid expense and other assets for fiscal 2023 was $75.88K.
- CAPRICOR THERAPEUTICS, INC. increase (decrease) in prepaid expense and other assets for fiscal 2022 was -$240.04K, a 261.40% decline from fiscal 2021.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 3 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 12 month | Increase (Decrease) in Prepaid Expense and Other Assets 71 month | Increase (Decrease) in Prepaid Expense and Other Assets 74 month | Increase (Decrease) in Prepaid Expense and Other Assets 77 month | Increase (Decrease) in Prepaid Expense and Other Assets 80 month | Increase (Decrease) in Prepaid Expense and Other Assets 83 month | Increase (Decrease) in Prepaid Expense and Other Assets 86 month | Increase (Decrease) in Prepaid Expense and Other Assets 89 month | Increase (Decrease) in Prepaid Expense and Other Assets 92 month | Increase (Decrease) in Prepaid Expense and Other Assets 95 month | Increase (Decrease) in Prepaid Expense and Other Assets 98 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$81.83K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$1.06M 10-Q · filed 2026-08-14 | $2.26M derived: sum of 3 quarters · filed 2026-08-14 | $3.23M derived: sum of 4 quarters · filed 2026-08-14 | |||||||||||||
| 2026-03-31 | -$979.78K 10-Q · filed 2026-05-13 | $2.35M derived: sum of 2 quarters · filed 2026-05-13 | $3.31M derived: sum of 3 quarters · filed 2026-05-13 | $3.17M derived: sum of 4 quarters · filed 2026-08-14 | |||||||||||||
| 2025-12-31 | $3.33M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-17 | $4.29M derived: sum of 2 quarters · filed 2026-03-17 | $4.15M derived: sum of 3 quarters · filed 2026-08-14 | $4.09M 10-K · filed 2026-03-17 | |||||||||||||
| 2025-09-30 | $966.33K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $823.56K derived: sum of 2 quarters · filed 2026-08-14 | $768.09K 10-Q · filed 2025-11-10 | $1.79M derived: sum of 4 quarters · filed 2026-08-14 | |||||||||||||
| 2025-06-30 | -$142.77K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$198.24K 10-Q · filed 2026-08-14 | $820.05K derived: sum of 3 quarters · filed 2026-08-14 | $367.58K derived: sum of 4 quarters · filed 2026-08-14 | |||||||||||||
| 2025-03-31 | -$55.47K 10-Q · filed 2026-05-13 | -$87.15K 10-Q · filed 2025-05-14 | $962.82K derived: sum of 2 quarters · filed 2026-05-13 | $510.35K derived: sum of 3 quarters · filed 2026-05-13 | $273.11K derived: sum of 4 quarters · filed 2026-05-13 | ||||||||||||
| 2024-12-31 | $1.02M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-17 | $565.83K derived: sum of 2 quarters · filed 2026-03-17 | $328.58K derived: sum of 3 quarters · filed 2026-03-17 | $458.65K 10-K · filed 2026-03-17 | |||||||||||||
| 2024-09-30 | -$452.46K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$689.71K derived: sum of 2 quarters · filed 2025-11-10 | -$559.64K 10-Q · filed 2025-11-10 | -$610.71K 10-Q · filed 2024-11-14 | -$22.28K derived: sum of 4 quarters · filed 2025-11-10 | ||||||||||||
| 2024-06-30 | -$237.24K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | -$107.17K 10-Q · filed 2025-08-11 | -$158.56K 10-Q · filed 2024-08-08 | $430.19K derived: sum of 3 quarters · filed 2025-08-11 | $304.77K derived: sum of 4 quarters · filed 2025-08-11 | ||||||||||||
| 2024-03-31 | $130.07K 10-Q · filed 2025-05-14 | $667.43K derived: sum of 2 quarters · filed 2025-05-14 | $542.01K derived: sum of 3 quarters · filed 2025-05-14 | $250.75K derived: sum of 4 quarters · filed 2025-05-14 | |||||||||||||
| 2023-12-31 | $537.36K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-26 | $411.94K derived: sum of 2 quarters · filed 2025-03-26 | $120.68K derived: sum of 3 quarters · filed 2025-03-26 | $75.88K 10-K · filed 2025-03-26 | |||||||||||||
| 2023-09-30 | -$125.42K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -$416.68K derived: sum of 2 quarters · filed 2024-11-14 | -$461.48K 10-Q · filed 2024-11-14 | $114.73K derived: sum of 4 quarters · filed 2024-11-14 | |||||||||||||
| 2023-06-30 | -$291.26K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$336.06K 10-Q · filed 2024-08-08 | $240.15K derived: sum of 3 quarters · filed 2024-08-08 | -$75.43K derived: sum of 4 quarters · filed 2024-08-08 | |||||||||||||
| 2023-03-31 | -$44.80K 10-Q · filed 2024-05-14 | $531.41K derived: sum of 2 quarters · filed 2024-05-14 | $215.82K derived: sum of 3 quarters · filed 2024-05-14 | -$68.15K derived: sum of 4 quarters · filed 2024-05-14 | |||||||||||||
| 2022-12-31 | $576.21K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-11 | $260.62K derived: sum of 2 quarters · filed 2024-03-11 | -$23.35K derived: sum of 3 quarters · filed 2024-03-11 | -$240.04K 10-K · filed 2024-03-11 | |||||||||||||
| 2022-09-30 | -$315.58K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | -$599.56K derived: sum of 2 quarters · filed 2023-11-14 | -$816.25K 10-Q · filed 2023-11-14 | $64.78K derived: sum of 4 quarters · filed 2023-11-14 | |||||||||||||
| 2022-06-30 | -$283.98K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | -$500.67K 10-Q · filed 2023-08-08 | $380.36K derived: sum of 3 quarters · filed 2023-08-08 | $5.93K derived: sum of 4 quarters · filed 2023-08-08 | |||||||||||||
| 2022-03-31 | -$216.69K 10-Q · filed 2023-05-12 | $664.34K derived: sum of 2 quarters · filed 2023-05-12 | $289.91K derived: sum of 3 quarters · filed 2023-05-12 | $206.89K derived: sum of 4 quarters · filed 2023-05-12 | |||||||||||||
| 2021-12-31 | $881.03K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-17 | $506.60K derived: sum of 2 quarters · filed 2023-03-17 | $423.58K derived: sum of 3 quarters · filed 2023-03-17 | $148.73K 10-K · filed 2023-03-17 | |||||||||||||
| 2021-09-30 | -$374.43K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -$457.45K derived: sum of 2 quarters · filed 2022-11-10 | -$732.30K 10-Q · filed 2022-11-10 | ||||||||||||||
| 2021-06-30 | -$83.02K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | -$357.87K 10-Q · filed 2022-08-12 | |||||||||||||||
| 2021-03-31 | -$274.85K 10-Q · filed 2022-05-11 | ||||||||||||||||
| 2013-09-30 | -$29.76K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | -$82.42K derived: sum of 2 quarters · filed 2013-11-14 | -$86.94K 10-Q · filed 2013-11-14 | -$117.87K derived: sum of 4 quarters · filed 2013-11-14 | $37.98K 10-Q · filed 2013-11-14 | ||||||||||||
| 2013-06-30 | -$52.66K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14 | -$57.17K 10-Q · filed 2013-08-14 | -$88.10K derived: sum of 3 quarters · filed 2013-08-14 | -$96.93K derived: sum of 4 quarters · filed 2013-11-14 | $67.74K 10-Q · filed 2013-08-14 | ||||||||||||
| 2013-03-31 | -$4.52K 10-Q · filed 2013-06-21 | -$35.45K derived: sum of 2 quarters · filed 2013-06-21 | -$44.27K derived: sum of 3 quarters · filed 2013-11-14 | -$99.99K derived: sum of 4 quarters · filed 2013-11-14 | $120.39K 10-Q · filed 2013-06-21 | ||||||||||||
| 2012-12-31 | -$30.93K derived: 10-K 12 month − 10-Q 9 month · filed 2013-06-21 | -$39.75K derived: sum of 2 quarters · filed 2013-11-14 | -$95.47K derived: sum of 3 quarters · filed 2013-11-14 | -$146.39K 10-K · filed 2013-06-21 | $124.91K 10-K · filed 2013-06-21 | ||||||||||||
| 2012-09-30 | -$8.82K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | -$64.55K derived: sum of 2 quarters · filed 2013-11-14 | -$115.46K 10-Q · filed 2013-11-14 | -$264.81K derived: sum of 4 quarters · filed 2013-11-14 | $155.84K 10-Q · filed 2013-06-21 | ||||||||||||
| 2012-06-30 | -$55.72K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14 | -$106.63K 10-Q · filed 2013-08-14 | -$255.99K derived: sum of 3 quarters · filed 2013-08-14 | -$215.21K derived: sum of 4 quarters · filed 2013-08-14 | $164.66K 10-Q/A · filed 2012-09-10 | ||||||||||||
| 2012-03-31 | -$50.91K 10-Q · filed 2013-06-21 | -$200.27K derived: sum of 2 quarters · filed 2013-06-21 | -$159.49K derived: sum of 3 quarters · filed 2013-06-21 | -$7.44K derived: sum of 4 quarters · filed 2013-06-21 | $220.39K 10-Q · filed 2012-05-15 | ||||||||||||
| 2011-12-31 | -$149.35K derived: 10-K 12 month − 10-Q 9 month · filed 2013-06-21 | -$108.58K derived: sum of 2 quarters · filed 2013-06-21 | $43.48K derived: sum of 3 quarters · filed 2013-06-21 | $52.20K 10-K · filed 2013-06-21 | $271.30K 10-K · filed 2012-04-02 | ||||||||||||
| 2011-09-30 | $40.78K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2013-06-21 | $192.83K derived: sum of 2 quarters · filed 2013-06-21 | $201.56K 10-Q · filed 2013-06-21 | $116.58K derived: sum of 4 quarters · filed 2013-06-21 | $420.65K 10-Q · filed 2011-11-14 | ||||||||||||
| 2011-06-30 | $152.05K derived: 10-Q/A 6 month − 10-Q 3 month · filed 2012-09-10 | $160.78K 10-Q/A · filed 2012-09-10 | $75.80K derived: sum of 3 quarters · filed 2012-09-10 | $142.69K derived: sum of 4 quarters · filed 2012-09-10 | $379.88K 10-Q · filed 2011-08-15 | ||||||||||||
| 2011-03-31 | $8.73K 10-Q · filed 2012-05-15 | -$76.25K derived: sum of 2 quarters · filed 2012-05-15 | -$9.36K derived: sum of 3 quarters · filed 2012-05-15 | ||||||||||||||
| 2010-12-31 | -$84.98K derived: 10-K 12 month − 10-Q 9 month · filed 2012-04-02 | -$18.09K derived: sum of 2 quarters · filed 2012-04-02 | -$38.64K 10-K · filed 2012-04-02 | ||||||||||||||
| 2010-09-30 | $66.89K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14 | $46.34K 10-Q · filed 2011-11-14 | |||||||||||||||
| 2010-06-30 | -$20.55K 10-Q · filed 2011-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |